Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Clinical and Experimental Rheumatology|December 4, 2015
Epidemiology of Takayasu's arteritis in TurkeyMerih Birlik, Yasin Kücükyavas, Kenan Aksu, et al.
The Pediatric Infectious Disease Journal|October 13, 2005
Acute trichinellosis in children compared with adultsDurgul Ozdemir, Hasan Ozkan, Nurullah Akkoc, et al.
Journal of Infection in Developing Countries|July 29, 2023
How has the COVID-19 pandemic affected our rheumatology patients using biological/targeted DMARDs?Semih Gulle, Yesim Erez, Ali Karakas, et al.
Arthritis Research & Therapy|December 25, 2012
Ghrelin and adipokines as circulating markers of disease activity in patients with Takayasu arteritisHatice Yilmaz, Vedat Gerdan, Didem Kozaci, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|December 14, 2018
The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish societyYaşar Murat Taş, Gözde Derviş Hakim, Pembe Keskinoğlu, et al.
Arthritis and Rheumatism|June 10, 2010
Increased prevalence of M694V in patients with ankylosing spondylitis: additional evidence for a link with familial mediterranean feverNurullah Akkoc, Ismail Sari, Servet Akar, et al.
Rheumatology International|October 8, 2015
A relationship between spinal new bone formation in ankylosing spondylitis and the sonographically determined Achilles tendon enthesophytesSibel Zehra Aydin, Meryem Can, Fatma Alibaz-Oner, et al.
Turkish Journal of Medical Sciences|May 30, 2024
Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: results from the TURKBİO registryAhmet Karataş, Rabia Pişkin Sağir, Süleyman Serdar Koca, et al.
Clinical Rheumatology|February 7, 2025
Treatment with nintedanib is as effective and safe in patients with other connective tissue diseases (CTDs)-interstitial lung disease (ILD) as in patients with systemic sclerosis-ILD: A multicenter retrospective studySalim Mısırcı, Ali Ekin, Burcu Yağız, et al.
Immunity, Inflammation and Disease|December 22, 2023
Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypesDuygu Temiz Karadağ, Andac Komac, Yesim Erez, et al.
Pageof 9